GALT GALECTIN THERAPEUTICS INC

Nasdaq galectintherapeutics.com


$ 5.10 $ -0.10 (-1.92 %)    

Wednesday, 15-Oct-2025 13:32:37 EDT
QQQ $ 599.49 $ -4.32 (-0.72 %)
DIA $ 462.24 $ -2.46 (-0.53 %)
SPY $ 662.31 $ -4.45 (-0.67 %)
TLT $ 90.60 $ -0.36 (-0.4 %)
GLD $ 385.67 $ -0.29 (-0.08 %)
$ 4.96
$ 5.20
$ 5.03 x 500
$ 5.20 x 100
$ 5.04 - $ 5.20
$ 0.73 - $ 6.55
344,415
na
nm
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-15-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-29-2024 12-31-2023 10-K
8 11-13-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-06-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 03-29-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-15-2017 03-31-2017 10-Q
35 03-28-2017 12-31-2016 10-K
36 11-08-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stitch-fix-posts-q4-results-joins-transocean-mbx-biosciences-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday. Shares of Stitch Fix, Inc....

 hc-wainwright--co-reiterates-buy-on-galectin-therapeutics-maintains-6-price-target

HC Wainwright & Co. analyst Matthew Keller reiterates Galectin Therapeutics (NASDAQ:GALT) with a Buy and maintains $6 pr...

 galectin-therapeutics-q2-eps-012-beats-016-estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of...

 hc-wainwright--co-assumes-galectin-therapeutics-at-buy-announces-price-target-of-6

HC Wainwright & Co. analyst Joseph Pantginis assumes Galectin Therapeutics (NASDAQ:GALT) with a Buy rating and announces...

 galectin-therapeutics-q1-eps-015-beats-020-estimate

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of...

 galectin-therapeutics-issues-presentation-highlighting-its-focused-pipeline-mash-cirrhosis-and-oncology-developing-galectin-based-therapeutics-to-improve-the-lives-of-patients-with-chronic-liver-diseases-and-cancer

https://docs.publicnow.com/viewDoc?hash_primary=6F7EA1F91A74272903B9A6CE2CA3BF2D89B3FA18

 hc-wainwright--co-reiterates-neutral-on-galectin-therapeuticsto-neutral

HC Wainwright & Co. analyst Ed Arce reiterates Galectin Therapeutics (NASDAQ:GALT) from Neutral to Neutral.

 hc-wainwright--co-downgrades-galectin-therapeutics-to-neutral

HC Wainwright & Co. analyst Ed Arce downgrades Galectin Therapeutics (NASDAQ:GALT) from Buy to Neutral.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION